The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission
Johan Burisch, Mirabella Zhao, Selwyn Odes, Peter De Cruz, Séverine Vermeire, Çharles N. Bernstein, Gilaad G. Kaplan, Dana Ďuricová, Dan Greenberg, Hans Olav Melberg, Mamoru Watanabe, Hyeong Sik Ahn, Laura E. Targownik, Valérie Pittet, Vito Annese, K.T. Park, Κωνσταντίνος Κατσάνος, Marte Lie Høivik, Željko Krznarić, María Chaparro, Edward V. Loftus, Péter L. Lakatos, Javier P. Gisbert, Willem A. Bemelman, Bjørn Moum, Richard B. Gearry, Michael D. Kappelman, Ailsa Hart, Marieke Pierik, Jane M. Andrews, Siew C. Ng, R. D’Incà, Pia Munkholm
Topics & Concepts
MedicineHepatologyHealth careInflammatory bowel diseaseUlcerative colitisProductivityDiseaseIntensive care medicineCommissionBusinessInternal medicineEconomic growthFinanceEconomicsInflammatory Bowel DiseaseMicroscopic ColitisTuberculosis Research and Epidemiology